Marie Mcavoy

Chief Scientific Officer at NanoSyrinx

Marie is a senior R&D leader with more than 20 years of drug discovery experience in the biotechnology industry and large pharma. She joined the company from GSK, where she was Senior Director in the Oncology Cell Therapy Research Unit. Marie has extensive knowledge of drug discovery across biopharms, cell and gene therapies and vaccines with a particular interest in the inter-relationships between safety, efficacy and manufacture. Throughout her career she has been accountable for delivering, reviewing and approving non-clinical safety and pharmacology packages to support non-regulatory project decisions and regulatory submissions.

Marie holds a Ph.D. in Rheumatology and Immunology from University of Birmingham, UK.

Links

Timeline

  • Chief Scientific Officer

    March, 2022 - present